Providing an overview on antipsychotics: schizophrenia a psychiatric challenge? A 2017 Update

  • Natalie Schellack Sefako Makgatho Health Sciences University
  • M Matlala Sefako Makgatho Health Sciences University
Keywords: antipsychotics, first generation antipsychotics, second generation antipsychotics, schizophrenia

Abstract

Psychosis is an umbrella term used in the description of various conditions involving delusions and hallucinations. This article focuses mainly on the management of schizophrenia. Schizophrenia is a complex disorder, which provides many pharmacotherapy-related challenges. Advances have been made in the treatment of the condition; however, this requires a team approach, with the pharmacist having to monitor treatment both for safety and efficacy. The involvement of medicines that might modulate the N-methyl-D-aspartate (NMDA) receptors is an exciting development that should be monitored.

Author Biographies

Natalie Schellack, Sefako Makgatho Health Sciences University
BCur, BPharm, PhD (Pharmacy) Associate Professor Department of Pharmacy Faculty of Health Sciences Sefako Makgatho Health Sciences University
M Matlala, Sefako Makgatho Health Sciences University
BPharm, MSc (Med) Pharmacy, PhD (Pharmacy) Senior Lecturer School of Pharmacy Faculty of Health Sciences Sefako Makgatho Health Sciences University
Published
2017-06-07
Section
Reviews